Rationale and design of the intravenous iron for treatment of anemia before cardiac surgery trial

PS Myles, T Richards, A Klein, J Smith, EM Wood… - American Heart …, 2021 - Elsevier
Background Approximately 20% to 30% of patients awaiting cardiac surgery are anemic.
Anemia increases the likelihood of requiring a red cell transfusion and is associated with …
被引用次数：7 相关文章

[引用][C] Rationale and design of the intravenous iron for treatment of anemia before cardiac surgery trial

PS Myles, T Richards, A Klein, J Smith, EM Wood… - 2021 - dro.deakin.edu.au
Rationale and design of the intravenous iron for treatment of anemia before cardiac surgery
trial

Rationale and design of the intravenous iron for treatment of anemia before cardiac surgery trial

PS Myles, T Richards, A Klein, J Smith, EM Wood… - 2021 - pubmed.ncbi.nlm.nih.gov
Background Approximately 20% to 30% of patients awaiting cardiac surgery are anemic.
Anemia increases the likelihood of requiring a red cell transfusion and is associated with …

Rationale and design of the intravenous iron for treatment of anemia before cardiac surgery trial

PS Myles, T Richards, A Klein, J Smith… - American Heart …, 2021 - research.monash.edu
Background Approximately 20% to 30% of patients awaiting cardiac surgery are anemic.
Anemia increases the likelihood of requiring a red cell transfusion and is associated with …

Rationale and design of the intravenous iron for treatment of anemia before cardiac surgery trial.

PS Myles, T Richards, A Klein, J Smith… - American Heart …, 2021 - europepmc.org
Background Approximately 20% to 30% of patients awaiting cardiac surgery are anemic.
Anemia increases the likelihood of requiring a red cell transfusion and is associated with …
[PDF] gciamt.org

[PDF][PDF] Rationale and design of the intravenous iron for treatment of anemia before cardiac surgery trial

PS Myles, T Richards, A Klein, J Smith, EM Wood… - 2021 - gciamt.org
Background Approximately 20% to 30% of patients awaiting cardiac surgery are anemic.
Anemia increases the likelihood of requiring a red cell transfusion and is associated with …

Rationale and design of the intravenous iron for treatment of anemia before cardiac surgery trial

PS Myles, T Richards, A Klein… - American Heart …, 2021 - researchnow.flinders.edu.au
Background Approximately 20% to 30% of patients awaiting cardiac surgery are anemic.
Anemia increases the likelihood of requiring a red cell transfusion and is associated with …

[引用][C] Rationale and design of the intravenous iron for treatment of anemia before cardiac surgery trial

PS Myles, T Richards, A Klein, J Smith, EM Wood… - 2021 - dro.deakin.edu.au
Rationale and design of the intravenous iron for treatment of anemia before cardiac surgery
trial